SMURF2-targeting nacellins (Encycle)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSMURF2-targeting nacellins (Encycle)
Drug Alias NameN/A
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionUbiquitin-protein ligases inhibitors
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsFibrosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEncycle Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEncycle Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsFibrosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A